Variant report

Variant	nsv883255
Chromosome Location	chr5:178774860-178933269
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:1048)
CpG islands
(count:2505)
Chromatin interactive
region (count:55)
LncRNA
region (count:11)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:1048 , 50 per page) page: 1 2 3 4 5 6 7 ... 21

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr5:178920984-178921396	HepG2	liver:	n/a	n/a
2	ARID3A	chr5:178921008-178921368	K562	blood:	n/a	n/a
3	ARID3A	chr5:178931255-178932227	HepG2	liver:	n/a	n/a
4	BACH1	chr5:178867641-178867777	H1-hESC	embryonic stem cell:	n/a	n/a
5	BACH1	chr5:178782018-178782023	K562	blood:	n/a	n/a
6	BHLHE40	chr5:178800328-178800428	K562	blood:	n/a	n/a
7	BHLHE40	chr5:178867642-178867915	K562	blood:	n/a	chr5:178867741-178867750 chr5:178867742-178867751 chr5:178867742-178867751 chr5:178867743-178867752 chr5:178867736-178867757 chr5:178867740-178867753
8	BHLHE40	chr5:178868515-178868770	K562	blood:	n/a	chr5:178868635-178868644 chr5:178868636-178868645 chr5:178868634-178868647 chr5:178868630-178868651 chr5:178868636-178868645 chr5:178868637-178868646
9	BRCA1	chr5:178932135-178932152	HepG2	liver:	n/a	n/a
10	CBX3	chr5:178826992-178827587	K562	blood:	n/a	n/a
11	CBX3	chr5:178827067-178827261	K562	blood:	n/a	n/a
12	CBX3	chr5:178820032-178820533	HCT-116	colon:	n/a	n/a
13	CBX3	chr5:178882860-178883255	K562	blood:	n/a	n/a
14	CEBPB	chr5:178913800-178913866	HepG2	liver:	n/a	n/a
15	CEBPB	chr5:178858431-178858818	A549	lung:	n/a	n/a
16	CEBPB	chr5:178931609-178932069	HepG2	liver:	n/a	n/a
17	CEBPB	chr5:178898812-178899126	Hela-S3	cervix:	n/a	n/a
18	CEBPB	chr5:178882280-178882457	Hela-S3	cervix:	n/a	n/a
19	CEBPB	chr5:178898795-178899125	HepG2	liver:	n/a	n/a
20	CEBPB	chr5:178780118-178780254	K562	blood:	n/a	n/a
21	CEBPB	chr5:178901817-178902203	MCF-7	breast:	n/a	n/a
22	CEBPB	chr5:178858474-178858798	K562	blood:	n/a	n/a
23	CEBPB	chr5:178783581-178783974	IMR90	lung:	n/a	chr5:178783766-178783775 chr5:178783815-178783826 chr5:178783813-178783824 chr5:178783865-178783878 chr5:178783765-178783776
24	CEBPB	chr5:178786252-178786390	K562	blood:	n/a	chr5:178786328-178786339
25	CEBPB	chr5:178882230-178882319	A549	lung:	n/a	n/a
26	CEBPB	chr5:178858409-178858867	MCF-7	breast:	n/a	n/a
27	CEBPB	chr5:178786316-178786363	A549	lung:	n/a	chr5:178786328-178786339
28	CEBPB	chr5:178820068-178820405	MCF-7	breast:	n/a	n/a
29	CEBPB	chr5:178901904-178902149	IMR90	lung:	n/a	n/a
30	CEBPB	chr5:178858455-178858788	IMR90	lung:	n/a	n/a
31	CEBPB	chr5:178920783-178920906	K562	blood:	n/a	n/a
32	CEBPB	chr5:178820035-178820283	K562	blood:	n/a	n/a
33	CEBPB	chr5:178901823-178902191	MCF-7	breast:	n/a	n/a
34	CEBPB	chr5:178858452-178858788	H1-hESC	embryonic stem cell:	n/a	n/a
35	CEBPB	chr5:178858441-178858825	Hela-S3	cervix:	n/a	n/a
36	CEBPB	chr5:178783645-178783928	A549	lung:	n/a	chr5:178783766-178783775 chr5:178783815-178783826 chr5:178783813-178783824 chr5:178783865-178783878 chr5:178783765-178783776
37	CEBPB	chr5:178898849-178899101	K562	blood:	n/a	n/a
38	CEBPB	chr5:178786162-178786480	Hela-S3	cervix:	n/a	chr5:178786328-178786339
39	CEBPB	chr5:178791997-178792197	Hela-S3	cervix:	n/a	n/a
40	CEBPB	chr5:178858449-178858788	HepG2	liver:	n/a	n/a
41	CEBPB	chr5:178820041-178820297	A549	lung:	n/a	n/a
42	CEBPB	chr5:178918785-178918864	HepG2	liver:	n/a	chr5:178918811-178918822
43	CEBPB	chr5:178921088-178921413	Hela-S3	cervix:	n/a	n/a
44	CEBPB	chr5:178819993-178820453	IMR90	lung:	n/a	n/a
45	CEBPB	chr5:178783646-178783964	Hela-S3	cervix:	n/a	chr5:178783766-178783775 chr5:178783815-178783826 chr5:178783813-178783824 chr5:178783865-178783878 chr5:178783765-178783776
46	CEBPB	chr5:178918660-178918869	IMR90	lung:	n/a	chr5:178918811-178918822
47	CEBPB	chr5:178901917-178902069	HepG2	liver:	n/a	n/a
48	CEBPB	chr5:178901825-178902196	ECC-1	luminal epithelium:	n/a	n/a
49	CEBPB	chr5:178901832-178902147	K562	blood:	n/a	n/a
50	CEBPB	chr5:178901859-178902134	K562	blood:	n/a	n/a

(count:2505 , 50 per page) page: 1 2 3 4 5 6 7 ... 51

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr5:178801647-178801697	HEK293	kidney:	embryo
2	chr5:178835980-178836030	NHDF-neo	bronchial:	n/a
3	chr5:178882605-178882655	NHDF-neo	bronchial:	n/a
4	chr5:178854586-178854636	SK-N-MC	brain:	n/a
5	chr5:178801647-178801697	HEK293	kidney:	embryo
6	chr5:178835980-178836030	NHDF-neo	bronchial:	n/a
7	chr5:178882605-178882655	NHDF-neo	bronchial:	n/a
8	chr5:178854586-178854636	SK-N-MC	brain:	n/a
9	chr5:178801332-178801382	AG09309	skin:	n/a
10	chr5:178797893-178797943	IMR90	lung:	fetal
11	chr5:178882763-178882813	HCPEpiC	choroid plexus:	n/a
12	chr5:178902790-178902840	ECC-1	luminal epithelium:	n/a
13	chr5:178854265-178854315	LNCaP	prostate:	n/a
14	chr5:178903057-178903107	GM12892	blood:	n/a
15	chr5:178801500-178801550	BJ	skin:	n/a
16	chr5:178808910-178808960	K562	blood:	n/a
17	chr5:178835885-178835935	SK-N-MC	brain:	n/a
18	chr5:178833490-178833540	AG09309	skin:	n/a
19	chr5:178789651-178789701	SK-N-SH_RA	brain:	n/a
20	chr5:178801647-178801697	AoSMC	blood vessel:	n/a
21	chr5:178801647-178801697	AG09309	skin:	n/a
22	chr5:178775192-178775242	GM19239	blood:	n/a
23	chr5:178835885-178835935	AG10803	skin:	n/a
24	chr5:178781563-178781613	MCF10A-Er-Src	breast:	n/a
25	chr5:178899789-178899839	HL-60	blood:	n/a
26	chr5:178781563-178781613	GM19239	blood:	n/a
27	chr5:178800355-178800405	NH-A	brain:	n/a
28	chr5:178846740-178846790	HNPCEpiC	eye:	n/a
29	chr5:178854758-178854808	AG10803	skin:	n/a
30	chr5:178854502-178854552	ovcar-3	ovarian:	n/a
31	chr5:178799709-178799759	Hepatocyte	liver:	n/a
32	chr5:178784097-178784147	AG04449	skin:	fetal
33	chr5:178899812-178899862	HRE	kidney:	n/a
34	chr5:178902699-178902749	HNPCEpiC	eye:	n/a
35	chr5:178775192-178775242	NT2-D1	testis:	n/a
36	chr5:178797893-178797943	HEK293	kidney:	embryo
37	chr5:178913683-178913733	GM12878	blood:	n/a
38	chr5:178805558-178805608	HRE	kidney:	n/a
39	chr5:178835980-178836030	RPTEC	kidney:	n/a
40	chr5:178854758-178854808	HMEC	breast:	n/a
41	chr5:178800304-178800354	Hela-S3	cervix:	n/a
42	chr5:178799709-178799759	HL-60	blood:	n/a
43	chr5:178808910-178808960	GM06990	blood:	n/a
44	chr5:178882763-178882813	HAEpiC	amniotic membrane:	n/a
45	chr5:178801332-178801382	MCF-7	breast:	n/a
46	chr5:178803207-178803257	HepG2	liver:	n/a
47	chr5:178854758-178854808	LNCaP	prostate:	n/a
48	chr5:178808910-178808960	AG10803	skin:	n/a
49	chr5:178800355-178800405	LNCaP	prostate:	n/a
50	chr5:178781563-178781613	NH-A	brain:	n/a

(count:55 , 50 per page) page: 1 2

No.	Distal block	Cell Line	Cell type
1	chr5:178793109..178796105-chr5:179125384..179128079,2	K562	blood:
2	chr5:178847716..178849702-chr5:178850729..178853201,2	K562	blood:
3	chr5:178807790..178810700-chr5:178813434..178815392,2	MCF-7	breast:
4	chr5:178786828..178788661-chr5:178798258..178800552,2	K562	blood:
5	chr5:178907766..178909631-chr5:178910623..178913270,3	K562	blood:
6	chr5:178848461..178850011-chr5:178850961..178853110,2	MCF-7	breast:
7	chr5:178774195..178776525-chr5:178779659..178783563,3	K562	blood:
8	chr5:178837251..178839356-chr5:178856114..178858488,2	MCF-7	breast:
9	chr5:178219841..178220793-chr5:178920740..178921735,2	MCF-7	breast:
10	chr5:178921207..178921791-chr5:179095335..179095939,2	K562	blood:
11	chr5:177708522..177710701-chr5:178921263..178923252,2	K562	blood:
12	chr5:178802308..178804471-chr5:178807615..178809965,2	K562	blood:
13	chr5:178687965..178688655-chr5:178920708..178921301,2	K562	blood:
14	chr5:178871548..178873217-chr5:178880850..178883062,2	MCF-7	breast:
15	chr5:178901161..178903409-chr5:178906875..178908641,2	MCF-7	breast:
16	chr5:178892938..178894678-chr5:178896634..178898137,2	K562	blood:
17	chr5:178688082..178688899-chr5:178920410..178921212,2	MCF-7	breast:
18	chr5:178219922..178220838-chr5:178920668..178921270,2	MCF-7	breast:
19	chr5:178799420..178802506-chr5:178805933..178808859,3	K562	blood:
20	chr5:178840253..178841953-chr5:178842013..178844118,2	K562	blood:
21	chr5:178907766..178909631-chr5:178910623..178913270,3	K562	blood:
22	chr5:178923732..178926017-chr5:178977562..178979960,2	MCF-7	breast:
23	chr5:178795348..178797290-chr5:178808669..178810729,2	K562	blood:
24	chr5:178815571..178817876-chr5:178818215..178820763,3	MCF-7	breast:
25	chr5:178882272..178884920-chr5:179049238..179052060,2	K562	blood:
26	chr5:178662646..178664463-chr5:178900746..178903231,2	K562	blood:
27	chr5:178786828..178788661-chr5:178798258..178800552,2	K562	blood:
28	chr5:178844770..178846299-chr5:178846428..178847929,2	MCF-7	breast:
29	chr5:178843393..178845957-chr5:178846634..178848163,2	K562	blood:
30	chr5:178807790..178810700-chr5:178813434..178815392,2	MCF-7	breast:
31	chr5:178844770..178846299-chr5:178846428..178847929,2	MCF-7	breast:
32	chr5:178834706..178836824-chr5:178848454..178851441,2	K562	blood:
33	chr5:178770291..178772174-chr5:178775649..178777213,2	MCF-7	breast:
34	chr5:178840253..178841953-chr5:178842013..178844118,2	K562	blood:
35	chr5:178593773..178595177-chr5:178920715..178921686,6	MCF-7	breast:
36	chr5:178811806..178815884-chr5:178836936..178839970,3	MCF-7	breast:
37	chr5:178905653..178907978-chr5:178976399..178978448,2	MCF-7	breast:
38	chr12:72186780..72187498-chr5:178846162..178846680,2	MCF-7	breast:
39	chr5:178762053..178764261-chr5:178817559..178819340,2	K562	blood:
40	chr5:178795348..178797290-chr5:178808669..178810729,2	K562	blood:
41	chr5:178912346..178914624-chr5:178918648..178920688,2	K562	blood:
42	chr5:178837251..178839356-chr5:178856114..178858488,2	MCF-7	breast:
43	chr5:178774195..178776525-chr5:178779659..178783563,3	K562	blood:
44	chr5:178780858..178782954-chr5:178784606..178786505,2	MCF-7	breast:
45	chr5:178802308..178804471-chr5:178807615..178809965,2	K562	blood:
46	chr5:178780858..178782954-chr5:178784606..178786505,2	MCF-7	breast:
47	chr5:178848461..178850011-chr5:178850961..178853110,2	MCF-7	breast:
48	chr5:178912346..178914624-chr5:178918648..178920688,2	K562	blood:
49	chr5:178847716..178849702-chr5:178850729..178853201,2	K562	blood:
50	chr5:178834706..178836824-chr5:178848454..178851441,2	K562	blood:

(count:11 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-RUFY1-5	chr5:178815798-178815892	l_3076_chr5:178815797-178817202_testes
2	lnc-RUFY1-2	chr5:178804506-178804705	ENSG00000253979
3	lnc-RUFY1-1	chr5:178882416-178882818	XLOC_004674
4	lnc-RUFY1-5	chr5:178816320-178816597	l_3076_chr5:178815797-178817202_testes
5	lnc-RUFY1-1	chr5:178882939-178883096	XLOC_004674
6	lnc-RUFY1-5	chr5:178816913-178817202	l_3076_chr5:178815797-178817202_testes
7	lnc-ADAMTS2-2	chr5:178893834-178894126	NONHSAT105584
8	lnc-ADAMTS2-1	chr5:178804601-178804929	XLOC_005105
9	lnc-ADAMTS2-1	chr5:178805537-178805760	XLOC_005105
10	lnc-HNRNPH1-3	chr5:178930323-178930741	ENSG00000253652
11	lnc-RUFY1-2	chr5:178805707-178805866	ENSG00000253979

No data

Variant related genes	Relation type
ENSG00000253163	TF binding region
ADAMTS2	TF binding region
ENSG00000253979	TF binding region
ENSG00000250674	TF binding region
RN7SL71P	TF binding region
ENSG00000253617	TF binding region
ENSG00000253163	CpG island
ADAMTS2	CpG island
ENSG00000253979	CpG island
ENSG00000250674	CpG island
RN7SL71P	CpG island
ENSG00000253617	CpG island
ENSG00000127022	chromatin interactions
ENSG00000176783	chromatin interactions
ENSG00000253617	chromatin interactions
ENSG00000169045	chromatin interactions
ENSG00000264205	chromatin interactions
ENSG00000250674	chromatin interactions

Extended variants
information (count: 6636 )
Associated
traits (count: 105 )

Variant overlapped rSNPs/rCNVs (count:6636 , 50 per page) page: 1 2 3 4 5 6 7 ... 133

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs255027	chr5:178774860-178774861	Bivalent Enhancer Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs576470236	chr5:178774900-178774901	Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs560950207	chr5:178774909-178774910	Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs572658558	chr5:178774937-178774938	Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs147813119	chr5:178774991-178774992	Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs564831620	chr5:178775041-178775042	Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs532027183	chr5:178775049-178775050	Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs141323641	chr5:178775051-178775052	Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs377215791	chr5:178775078-178775079	Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
10	rs373243360	chr5:178775106-178775107	Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
11	rs562637200	chr5:178775116-178775117	Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs529768836	chr5:178775119-178775120	Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs142886414	chr5:178775160-178775161	Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
14	rs3857419	chr5:178775162-178775163	Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs151059414	chr5:178775195-178775196	Bivalent Enhancer Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
16	rs535186105	chr5:178775196-178775197	Bivalent Enhancer Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
17	rs140945013	chr5:178775198-178775199	Bivalent Enhancer Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
18	rs33903	chr5:178775199-178775200	Bivalent Enhancer Weak transcription	TF binding region CpG island	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
19	rs150186024	chr5:178775215-178775216	Bivalent Enhancer Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
20	rs191718263	chr5:178775224-178775225	Bivalent Enhancer Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
21	rs575558425	chr5:178775231-178775232	Bivalent Enhancer Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
22	rs536353287	chr5:178775285-178775286	Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
23	rs375067679	chr5:178775325-178775326	Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
24	rs146880310	chr5:178775347-178775348	Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
25	rs140697066	chr5:178775397-178775398	Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs182685799	chr5:178775407-178775408	Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs145891809	chr5:178775429-178775430	Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs576712088	chr5:178775462-178775463	Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs544460457	chr5:178775472-178775473	Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs562367132	chr5:178775475-178775476	Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs79007950	chr5:178775492-178775493	Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs547988242	chr5:178775500-178775501	Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs560278438	chr5:178775512-178775513	Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs570346444	chr5:178775569-178775570	Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs375556192	chr5:178775570-178775571	Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs528740793	chr5:178775572-178775573	Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs185537176	chr5:178775583-178775584	Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs572002020	chr5:178775619-178775620	Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs539354582	chr5:178775680-178775681	Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs551211161	chr5:178775701-178775702	Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs569171057	chr5:178775708-178775709	Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs536642039	chr5:178775768-178775769	Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs190200815	chr5:178775777-178775778	Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs554814438	chr5:178775791-178775792	Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs138452822	chr5:178775817-178775818	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs533773621	chr5:178775849-178775850	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs540570327	chr5:178775868-178775869	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs558346508	chr5:178775909-178775910	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs577445267	chr5:178775940-178775941	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs543287109	chr5:178775996-178775997	Bivalent Enhancer Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:105)

Disease	PMID	Source
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Medulloblastoma	21979893	CNVD
Phyllodes tumor	17334353	CNVD
Malaria	21533027	CNVD
Renal cell carcinoma	19461508	CNVD
Cancer	20164919	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Cancer	16751803	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Glioma	20126413	CNVD
Cancer	22429812	CNVD
Cancer	21637783	CNVD
Colorectal cancer	20709793	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Liposarcoma	21253554	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Leukemia	17361228	CNVD
Myelodysplastic syndrome	18508791	CNVD
5q-syndrome	17576883	CNVD
Gastric cancer	17908304	CNVD
Lung cancer	16740712	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Urothelial carcinoma	21177765	CNVD
Esophageal adenocarcinoma	19417022	CNVD
Barrett''s syndrome	19417022	CNVD
Thyroid cancer	19087340	CNVD
Acute myeloid leukemia	20729466	CNVD
lymphocytic leukemia	21291569	CNVD
Multiple myeloma	17550852	CNVD
Salivary gland tumor	18059337	CNVD
Renal cell carcinoma	19377443	CNVD
Lung cancer	18438408	CNVD
Gastrointestinal stromal cancer	19259404	CNVD
Renal cell carcinoma	18592004	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Prostate cancer	18632612	CNVD
epilepsy	18472482	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Sotos syndrome	21572526	CNVD
T-cell acute lymphoblastic leukemia	20065082	CNVD
Sotos syndrome	17561922	CNVD
Sotos syndrome	16773131	CNVD
Mental retardation	16773131	CNVD
Sotos syndrome	22470819	CNVD
Non-syndromic sensorineural hearing loss	20606397	CNVD
Acute myeloid leukemia	18000384	CNVD
Sudden cardiac death	19188705	CNVD
Basal cell lymphoma	16317097	CNVD
Chordoma	18071362	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Olfactory neuroblastoma	18408657	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
abnormal development	18461090	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Lung cancer	17297452	CNVD
Cancer	20164920	CNVD
small cell lung cancer	20016488	CNVD
Breast cancer	21509527	CNVD
Breast cancer	21804112	CNVD
Myelofibrosis	22110671	CNVD
Sotos syndrome	22283845	CNVD
Breast cancer	16272173	CNVD
Sotos syndrome	20503325	CNVD
Lung adenocarcinoma	17086460	CNVD
Congenital Hypertrichosis Syndrome	21636067	CNVD
T-cell acute lymphoblastic leukemia	19406988	CNVD
Breast cancer	19181860	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Ehlers-danlos syndrome	17576883	CNVD
Lung cancer	17086460	CNVD
Autism	19246517	CNVD
Basal cell lymphoma	19029149	CNVD
Diffuse large b-cell lymphoma	19029149	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD
Melanoma	20877625	CNVD

Chromatin state (count:678 , 50 per page) page: 1 2 3 4 5 6 7 ... 14

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr5:178773200-178775800	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin01	Skin
2	chr5:178773400-178782600	Weak transcription	Right Atrium	heart
3	chr5:178775400-178776200	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin02	Skin
4	chr5:178775800-178776000	Bivalent Enhancer	Fetal Muscle Trunk	muscle
5	chr5:178775800-178776000	Bivalent Enhancer	Fetal Stomach	stomach
6	chr5:178775800-178776000	Bivalent Enhancer	Right Ventricle	heart
7	chr5:178775800-178777000	Enhancers	Spleen	Spleen
8	chr5:178776000-178776200	Bivalent Enhancer	Fetal Muscle Leg	muscle
9	chr5:178776800-178777000	Enhancers	Fetal Brain Female	brain
10	chr5:178776800-178777000	Bivalent Enhancer	Fetal Muscle Trunk	muscle
11	chr5:178777000-178778000	Weak transcription	Spleen	Spleen
12	chr5:178777400-178778400	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
13	chr5:178777800-178778200	Enhancers	H1 Cell Line	embryonic stem cell
14	chr5:178778000-178778200	Enhancers	Spleen	Spleen
15	chr5:178778000-178778600	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
16	chr5:178778200-178778400	Enhancers	iPS-18 Cell Line	embryonic stem cell
17	chr5:178778200-178778600	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
18	chr5:178778200-178780400	Weak transcription	Spleen	Spleen
19	chr5:178778800-178780400	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
20	chr5:178780200-178780400	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
21	chr5:178780200-178780400	Enhancers	Adipose Nuclei	Adipose
22	chr5:178780200-178780800	Enhancers	Primary monocytes fromperipheralblood	blood
23	chr5:178780200-178780800	Enhancers	Monocytes-CD14+_RO01746	blood
24	chr5:178780400-178780600	Enhancers	Spleen	Spleen
25	chr5:178780400-178781000	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
26	chr5:178780400-178782600	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
27	chr5:178780400-178783000	Weak transcription	Adipose Nuclei	Adipose
28	chr5:178780600-178781200	Weak transcription	Spleen	Spleen
29	chr5:178780800-178782800	Weak transcription	Primary monocytes fromperipheralblood	blood
30	chr5:178780800-178783000	Weak transcription	Monocytes-CD14+_RO01746	blood
31	chr5:178781000-178782800	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
32	chr5:178781200-178781600	Enhancers	Breast Myoepithelial Primary Cells	Breast
33	chr5:178781200-178785200	Enhancers	Spleen	Spleen
34	chr5:178781600-178781800	Bivalent Enhancer	Fetal Muscle Trunk	muscle
35	chr5:178781800-178782000	Bivalent Enhancer	Placenta	Placenta
36	chr5:178781800-178783600	Enhancers	Lung	lung
37	chr5:178782000-178784600	Enhancers	Placenta	Placenta
38	chr5:178782400-178783600	Enhancers	Sigmoid Colon	Sigmoid Colon
39	chr5:178782600-178782800	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
40	chr5:178782600-178783600	Enhancers	Pancreas	Pancrea
41	chr5:178782600-178783800	Enhancers	Right Atrium	heart
42	chr5:178782600-178784600	Enhancers	Ovary	ovary
43	chr5:178782600-178785000	Enhancers	Fetal Lung	lung
44	chr5:178782800-178783000	ZNF genes & repeats	iPS DF 19.11 Cell Line	embryonic stem cell
45	chr5:178782800-178783000	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin01	Skin
46	chr5:178782800-178783400	Enhancers	Brain Hippocampus Middle	brain
47	chr5:178782800-178783400	Enhancers	Brain Inferior Temporal Lobe	brain
48	chr5:178782800-178783600	Flanking Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
49	chr5:178782800-178786600	Enhancers	Primary monocytes fromperipheralblood	blood
50	chr5:178783000-178783200	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links